{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:46:58Z","timestamp":1791827218932,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013129","name":"Ministry of SMEs and Startups","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jconrel.2019.06.021","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T07:48:56Z","timestamp":1561016936000},"page":"76-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Nose-to-brain delivery of hyaluronate \u2013 FG loop peptide conjugate for non-invasive hypoxic-ischemic encephalopathy therapy"],"prefix":"10.1016","volume":"307","author":[{"given":"Yun Seop","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Kyung","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyemin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Ho","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7718-6259","authenticated-orcid":false,"given":"Sei Kwang","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jconrel.2019.06.021_bb0005","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1111\/j.1471-4159.2008.05544.x","article-title":"NCAM-derived peptides function as agonists for the fibroblast growth factor receptor","volume":"106","author":"Hansen","year":"2008","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.jconrel.2019.06.021_bb0010","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1471-4159.2004.02779.x","article-title":"An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons","volume":"91","author":"Neiiendam","year":"2004","journal-title":"J. Neurochem."},{"issue":"17","key":"10.1016\/j.jconrel.2019.06.021_bb0015","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1523\/JNEUROSCI.0436-04.2004","article-title":"A synthetic neural cell adhesion molecule mimetic peptide promotes synaptogenesis, enhances presynaptic function, and facilitates memory consolidation","volume":"24","author":"Cambon","year":"2004","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.jconrel.2019.06.021_bb0020","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.neuroscience.2006.04.059","article-title":"A neural cell adhesion molecule-derived fibroblast growth factor receptor agonist, the FGL-peptide, promotes early postnatal sensorimotor development and enhances social memory retention","volume":"141","author":"Secher","year":"2006","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.jconrel.2019.06.021_bb0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neuroscience.2006.11.060","article-title":"A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by A\u03b225-35","volume":"145","author":"Klementiev","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.jconrel.2019.06.021_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.brainres.2008.05.088","article-title":"Antidepressant-like effects of intracerebroventricular FGF2 in rats","volume":"1224","author":"Turner","year":"2008","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.jconrel.2019.06.021_bb0035","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/j.1460-9568.2005.04345.x","article-title":"A synthetic NCAM-derived peptide, FGL, protects hippocampal neurons from ischemic insult both in vitro and in vivo","volume":"22","author":"Skibo","year":"2005","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.jconrel.2019.06.021_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001262","article-title":"Facilitation of AMPA receptor synaptic delivery as a molecular mechanism for cognitive enhancement","volume":"10","author":"Knafo","year":"2012","journal-title":"PLoS Biol."},{"issue":"8","key":"10.1016\/j.jconrel.2019.06.021_bb0045","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1460-9568.2008.06471.x","article-title":"Depression-like behaviour in neural cell adhesion molecule (NCAM)-deficient mice and its reversal by an NCAM-derived peptide, FGL","volume":"28","author":"Aonurm-Helm","year":"2008","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.jconrel.2019.06.021_bb0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1021\/cn400153g","article-title":"Impact of the neural cell adhesion molecule-derived peptide FGL on seizure progression and cellular alterations in the mouse kindling model","volume":"5","author":"Zellinger","year":"2014","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.jconrel.2019.06.021_bb0055","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.jconrel.2019.06.021_bb0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery\u2014possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2019.06.021_bb0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0169-409X(97)00059-8","article-title":"Nasal mucociliary clearance as a factor for nasal drug delivery","volume":"29","author":"Marttin","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.jconrel.2019.06.021_bb0070","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.progpolymsci.2014.07.010","article-title":"Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review","volume":"39","author":"Sosnik","year":"2014","journal-title":"Prog. Polym. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2019.06.021_bb0075","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.carbpol.2012.07.085","article-title":"Mucoadhesive properties of tamarind-seed polysaccharide\/hyaluronic acid mixtures: a nuclear magnetic resonance spectroscopy investigation","volume":"91","author":"Uccello-Barretta","year":"2013","journal-title":"Carbohydr. Polym."},{"issue":"33","key":"10.1016\/j.jconrel.2019.06.021_bb0080","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.1016\/j.biomaterials.2011.07.088","article-title":"Target specific hyaluronic acid-interferon alpha conjugate for the treatment of hepatitis C virus infection","volume":"32","author":"Yang","year":"2011","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.jconrel.2019.06.021_bb0085","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0169-409X(02)00023-6","article-title":"Mono-N-terminal poly (ethylene glycol)\u2013protein conjugates","volume":"54","author":"Kinstler","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.jconrel.2019.06.021_bb0090","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1517\/17425247.2011.561311","article-title":"Drug delivery strategies for Alzheimer's disease treatment","volume":"8","author":"Di Stefano","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"issue":"3","key":"10.1016\/j.jconrel.2019.06.021_bb0095","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jconrel.2011.03.016","article-title":"The effect of dextrin-rhEGF on the healing of full-thickness, excisional wounds in the (db\/db) diabetic mouse","volume":"152","author":"Hardwicke","year":"2011","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2019.06.021_bb0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nchem.1573","article-title":"A heparin-mimicking polymer conjugate stabilizes basic fibroblast growth factor","volume":"5","author":"Nguyen","year":"2013","journal-title":"Nat. Chem."},{"key":"10.1016\/j.jconrel.2019.06.021_bb0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biomaterials.2016.03.017","article-title":"Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro","volume":"93","author":"Altiok","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.06.021_bb0110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2015.03.024","article-title":"Nanoparticle-mediated growth factor delivery systems: a new way to treat Alzheimer's disease","volume":"206","author":"Lauzon","year":"2015","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2019.06.021_bb0115","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2019.06.021_bb0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2011.02.022","article-title":"Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration","volume":"151","author":"Wen","year":"2011","journal-title":"J. Control. Release"},{"issue":"18","key":"10.1016\/j.jconrel.2019.06.021_bb0125","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1016\/j.biomaterials.2006.01.038","article-title":"Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration","volume":"27","author":"Gao","year":"2006","journal-title":"Biomaterials"},{"issue":"36","key":"10.1016\/j.jconrel.2019.06.021_bb0130","doi-asserted-by":"crossref","first-page":"9888","DOI":"10.1016\/j.biomaterials.2011.09.004","article-title":"Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration","volume":"32","author":"Xia","year":"2011","journal-title":"Biomaterials"},{"issue":"36","key":"10.1016\/j.jconrel.2019.06.021_bb0135","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1016\/j.biomaterials.2013.08.036","article-title":"Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles","volume":"34","author":"Kanazawa","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.06.021_bb0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2014.06.053","article-title":"Quantitative analysis of drug delivery to the brain via nasal route","volume":"189","author":"Kozlovskaya","year":"2014","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2019.06.021_bb0145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2006.12.014","article-title":"Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies","volume":"118","author":"Charlton","year":"2007","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2019.06.021_bb0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/smll.200901158","article-title":"Effect of surface properties on nanoparticle-cell interactions","volume":"6","author":"Verma","year":"2010","journal-title":"Small"},{"issue":"7","key":"10.1016\/j.jconrel.2019.06.021_bb0155","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2019.06.021_bb0160","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.3390\/molecules14093754","article-title":"Nasal delivery of high molecular weight drugs","volume":"14","author":"Ozsoy","year":"2009","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.jconrel.2019.06.021_bb0165","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00223-002-0034-9","article-title":"Intranasal delivery of PEGylated salmon calcitonins: hypocalcemic effect in rats","volume":"73","author":"Lee","year":"2003","journal-title":"Calcif. Tissue Int."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2019.06.021_bb0170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijpharm.2017.07.077","article-title":"Enhancement of nose-to-brain delivery of hydrophilic macromolecules with stearate- or polyethylene glycol-modified arginine-rich peptide","volume":"530","author":"Kanazawa","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.06.021_bb0175","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12974-015-0251-6","article-title":"Sexually dimorphic outcomes and inflammatory responses in hypoxic-ischemic encephalopathy","volume":"12","author":"Mirza","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jconrel.2019.06.021_bb0180","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jneumeth.2004.04.029","article-title":"Infarct volume quantification in mouse focal cerebral ischemia: a comparison of triphenyltetrazolium chloride and cresyl violet staining techniques","volume":"139","author":"T\u00fcreyen","year":"2004","journal-title":"J. Neurosci. Methods"},{"issue":"3","key":"10.1016\/j.jconrel.2019.06.021_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120893","article-title":"Hypothermia augments neuroprotective activity of mesenchymal stem cells for neonatal hypoxic-ischemic encephalopathy","volume":"10","author":"Park","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2019.06.021_bb0190","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3389\/fneur.2015.00264","article-title":"Glial fibrillary acidic protein is not an early marker of injury in perinatal asphyxia and hypoxic-ischemic encephalopathy","volume":"6","author":"Looney","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jconrel.2019.06.021_bb0195","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.expneurol.2011.09.025","article-title":"A neural cell adhesion molecule-derived peptide, FGL, attenuates glial cell activation in the aged hippocampus","volume":"232","author":"Ojo","year":"2011","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.jconrel.2019.06.021_bb0200","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.22419","article-title":"Neuronal cell death in neonatal hypoxia-ischemia","volume":"69","author":"Northington","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jconrel.2019.06.021_bb0205","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/brainsci8080147","article-title":"Perinatal hypoxic-ischemic encephalopathy and neuroprotective peptide therapies: a case for cationic arginine-rich peptides (CARPs)","volume":"8","author":"Edwards","year":"2018","journal-title":"Brain Sci."},{"key":"10.1016\/j.jconrel.2019.06.021_bb0210","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s11481-016-9694-5","article-title":"The neural cell adhesion molecule-derived (NCAM)-peptide FG loop (FGL) mobilizes endogenous neural stem cells and promotes endogenous regenerative capacity after stroke","volume":"11","author":"Klein","year":"2016","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2019.06.021_bb0215","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0168-3659(94)90129-5","article-title":"Hyaluronic acid ester microspheres as a nasal delivery system for insulin","volume":"29","author":"Illum","year":"1994","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2019.06.021_bb0220","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejpb.2008.10.009","article-title":"Sodium hyaluronate as a mucoadhesive component in nasal formulation enhances delivery of molecules to brain tissue","volume":"72","author":"Horv\u00e1t","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919303426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919303426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:41:37Z","timestamp":1759160497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365919303426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":44,"alternative-id":["S0168365919303426"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.06.021","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nose-to-brain delivery of hyaluronate \u2013 FG loop peptide conjugate for non-invasive hypoxic-ischemic encephalopathy therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}